Glyco Mimetics
Pharmaceuticals, 9708 Medical Center Dr, Rockville, Maryland, 20850, United States, 51-200 Employees
Phone Number: 24********
Who is GLYCOMIMETICS
At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with cancers and inflammatory diseases such as acute myeloid leukemia and sickle cell dise...
Read More
-
Headquarters: 9708 Medical Center Dr, Rockville, Maryland, 20850, United States
-
Date Founded: 2003
-
Employees: 51-200
-
Revenue: $1 Million to $5 Million
-
Active Tech Stack: See technologies
Industry: Pharmaceuticals
SIC Code: 2834
|
NAICS Code: 446110 |
Show More
Does something look wrong? Fix it. | View contact records from GLYCOMIMETICS
GlycoMimetics Org Chart and Mapping
Email
Phone
Similar Companies to GlycoMimetics
Alnylam Pharmaceuticals
-
1001-5000
-
$ 500 Million to 1 Billion
Biotechnology Innovation Organization
-
51-200
-
$ 250 Million to 500 Million
CatenaBio
-
1-10
-
$ Under 1 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding GlycoMimetics
Answer: GlycoMimetics's headquarters are located at 9708 Medical Center Dr, Rockville, Maryland, 20850, United States
Answer: GlycoMimetics's phone number is 24********
Answer: GlycoMimetics's official website is https://glycomimetics.com
Answer: GlycoMimetics's revenue is $1 Million to $5 Million
Answer: GlycoMimetics's SIC: 2834
Answer: GlycoMimetics's NAICS: 446110
Answer: GlycoMimetics has 51-200 employees
Answer: GlycoMimetics is in Pharmaceuticals
Answer: GlycoMimetics top competitors include: Alnylam Pharmaceuticals , Biotechnology Innovation Organization , CatenaBio
Answer: GlycoMimetics contact info: Phone number: 24******** Website: https://glycomimetics.com
Answer: At GlycoMimetics, we are committed to helping to make a difference in the lives of people living with cancers and inflammatory diseases such as acute myeloid leukemia and sickle cell disease. Our mission is to improve outcomes for patients by advancing our research and clinical candidates, providing hope for patients as we strive to deliver breakthrough treatments. GlycoMimetics is a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies. Our leading researchers leverage their deep understanding of the role that carbohydrates play in cell recognition processes and use our proprietary chemistry platform to discover small molecule drugs, known as glycomimetics, which alter carbohydrate-mediated recognition in diverse disease states, including cancer and inflammation. We harness our development and commercial expertise to move our wholly-owned drug candidates from research through late-stage clinical development. We are a public company traded on the NASDAQ under the symbol GLYC.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month